General Information
Revision date
2020-09-30
Product name
Drospirenone and Ethinyl Estradiol Tablets USP
CAS No.
67392-87-4
Manufacturer Name
Cyndea
Icons in SDS
Company Information
company name
Camber Consumer care, Inc.
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible Health Do not prescribe Drospirenone and Ethinyl Estradiol Tablets USP to women who are known to have the following: • Renal impairment • Adrenal insufficiency • A high risk of arterial or venous thrombotic diseases. Examples include women who are known to: • Smoke, if over age 35 • Have deep vein thrombosis or pulmonary embolism, now or in the past • Have cerebrovascular disease • Have coronary artery disease • Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) • Have inherited or acquired hypercoagulopathies • Have uncontrolled hypertension • Have diabetes mellitus with vascular disease • Have headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35 • Undiagnosed abnormal uterine bleeding • Breast cancer or other estrogen- or progestin-sensitive cancer, now or in the past • Liver tumors, benign or malignant, or liver disease • Pregnancy, because there is no reason to use COCs during pregnancy
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
